Eichhorn, F., Klotz, L. V., Kriegsmann, M., Bischoff, H., Schneider, M., Muley, T., . . . Eichhorn, M. E. (2021). Neoadjuvant anti-programmed death-1 immunotherapy by pembrolizumab in resectable non-small cell lung cancer: First clinical experience. Lung cancer, 153, . https://doi.org/10.1016/j.lungcan.2021.01.018
Chicago-Zitierstil (17. Ausg.)Eichhorn, Florian, et al. "Neoadjuvant Anti-programmed Death-1 Immunotherapy by Pembrolizumab in Resectable Non-small Cell Lung Cancer: First Clinical Experience." Lung Cancer 153 (2021). https://doi.org/10.1016/j.lungcan.2021.01.018.
MLA-Zitierstil (9. Ausg.)Eichhorn, Florian, et al. "Neoadjuvant Anti-programmed Death-1 Immunotherapy by Pembrolizumab in Resectable Non-small Cell Lung Cancer: First Clinical Experience." Lung Cancer, vol. 153, 2021, https://doi.org/10.1016/j.lungcan.2021.01.018.